Bast MA - Search Results

1

Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.

Landsburg DJ, Falkiewicz MK, Petrich AM, Chu BA, Behdad A, Li S, Medeiros LJ, Cassaday RD, Reddy NM, Bast MA, Vose JM, Kruczek KR, Smith SE, Patel P, Hernandez-Ilizaliturri F, Karmali R, Rajguru S, Yang DT, Maly JJ, Blum KA, Zhao W, Vanslambrouck C, Nabhan C. Landsburg DJ, et al. Among authors: bast ma. Br J Haematol. 2016 Nov;175(4):631-640. doi: 10.1111/bjh.14282. Epub 2016 Jul 29. Br J Haematol. 2016. PMID: 27469075 Free PMC article.

2

Histologic grade does not predict prognosis in optimally treated, advanced-stage nodular sclerosing Hodgkin's disease.

Masih AS, Weisenburger DD, Vose JM, Bast MA, Armitage JO. Masih AS, et al. Among authors: bast ma. Cancer. 1992 Jan 1;69(1):228-32. doi: 10.1002/1097-0142(19920101)69:1<228::aid-cncr2820690137>3.0.co;2-9. Cancer. 1992. PMID: 1727667

3

Low proliferative activity is associated with a favorable prognosis in peripheral T-cell lymphoma.

Grierson HL, Wooldridge TN, Purtilo DT, Pierson J, Bast M, Wooldridge L, Armitage JO, Weisenburger DD. Grierson HL, et al. Cancer Res. 1990 Aug 15;50(16):4845-8. Cancer Res. 1990. PMID: 2379148

4

Peripheral T-cell lymphoma.

Armitage JO, Greer JP, Levine AM, Weisenburger DD, Formenti SC, Bast M, Conley S, Pierson J, Linder J, Cousar JB, et al. Armitage JO, et al. Cancer. 1989 Jan 1;63(1):158-63. doi: 10.1002/1097-0142(19890101)63:1<158::aid-cncr2820630125>3.0.co;2-b. Cancer. 1989. PMID: 2783376

5

Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.

Vose JM, Anderson JR, Bierman PJ, Bast M, Weisenburger D, Chan WC, Bishop MR, Armitage JO. Vose JM, et al. Semin Hematol. 1994 Apr;31(2 Suppl 3):4-8. Semin Hematol. 1994. PMID: 7521065 Clinical Trial. No abstract available.

6

The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma.

Stewart DA, Vose JM, Weisenburger DD, Anderson JR, Ruby EI, Bast MA, Bierman PJ, Kessinger A, Armitage JO. Stewart DA, et al. Among authors: bast ma. Ann Oncol. 1995 Mar;6(3):263-6. doi: 10.1093/oxfordjournals.annonc.a059156. Ann Oncol. 1995. PMID: 7612492 Free article.

7

Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma.

Yan Y, Chan WC, Weisenburger DD, Anderson JR, Bast MA, Vose JM, Bierman PJ, Armitage JO. Yan Y, et al. Among authors: bast ma. J Clin Oncol. 1995 Jun;13(6):1336-42. doi: 10.1200/JCO.1995.13.6.1336. J Clin Oncol. 1995. PMID: 7751877

8

Prognostic value of cellular proliferation and histologic grade in follicular lymphoma.

Martin AR, Weisenburger DD, Chan WC, Ruby EI, Anderson JR, Vose JM, Bierman PJ, Bast MA, Daley DT, Armitage JO. Martin AR, et al. Among authors: bast ma. Blood. 1995 Jun 15;85(12):3671-8. Blood. 1995. PMID: 7780151 Free article.

9

Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients.

Gordon BG, Weisenburger DD, Warkentin PI, Anderson J, Sanger WG, Bast M, Gnarra D, Vose JM, Bierman PJ, Armitage JO, et al. Gordon BG, et al. Cancer. 1993 Jan 1;71(1):257-63. doi: 10.1002/1097-0142(19930101)71:1<257::aid-cncr2820710139>3.0.co;2-b. Cancer. 1993. PMID: 8380117

10

Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group.

Anderson JR, Vose JM, Bierman PJ, Weisenberger DD, Sanger WG, Pierson J, Bast M, Armitage JO. Anderson JR, et al. J Clin Oncol. 1993 Feb;11(2):218-24. doi: 10.1200/JCO.1993.11.2.218. J Clin Oncol. 1993. PMID: 8426197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page